A review on CRISPR-Cas system based applications in Oncology
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Auteur principal: | Sadia, Mir |
---|---|
Autres auteurs: | Sayka Khan, Tanisha Tabassum |
Format: | Thèse |
Langue: | en_US |
Publié: |
Brac University
2022
|
Sujets: | |
Accès en ligne: | http://hdl.handle.net/10361/17517 |
Documents similaires
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
par: Maria, Amatul
Publié: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
par: Shaikat, Mahdi Mubin
Publié: (2023) -
Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
par: Nwabunwanne, Eze Uchenna
Publié: (2022) -
A review on CRISPR Technology as an Antiviral Tool
par: Srishti, Sanjida Ahmed
Publié: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
par: Eva, Israt Ara Jannat
Publié: (2023)